High frequencies of dermatological complications in children using insulin pumps or sensors

Research output: Contribution to journalJournal articlepeer-review

Standard

High frequencies of dermatological complications in children using insulin pumps or sensors. / Berg, Anna Korsgaard; Olsen, Birthe Susanne; Thyssen, Jacob P; Zachariae, Claus; Simonsen, Anne Birgitte; Pilgaard, Kasper; Svensson, Jannet.

In: Pediatric Diabetes, Vol. 19, No. 4, 2018, p. 733-740.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Berg, AK, Olsen, BS, Thyssen, JP, Zachariae, C, Simonsen, AB, Pilgaard, K & Svensson, J 2018, 'High frequencies of dermatological complications in children using insulin pumps or sensors', Pediatric Diabetes, vol. 19, no. 4, pp. 733-740. https://doi.org/10.1111/pedi.12652

APA

Berg, A. K., Olsen, B. S., Thyssen, J. P., Zachariae, C., Simonsen, A. B., Pilgaard, K., & Svensson, J. (2018). High frequencies of dermatological complications in children using insulin pumps or sensors. Pediatric Diabetes, 19(4), 733-740. https://doi.org/10.1111/pedi.12652

Vancouver

Berg AK, Olsen BS, Thyssen JP, Zachariae C, Simonsen AB, Pilgaard K et al. High frequencies of dermatological complications in children using insulin pumps or sensors. Pediatric Diabetes. 2018;19(4):733-740. https://doi.org/10.1111/pedi.12652

Author

Berg, Anna Korsgaard ; Olsen, Birthe Susanne ; Thyssen, Jacob P ; Zachariae, Claus ; Simonsen, Anne Birgitte ; Pilgaard, Kasper ; Svensson, Jannet. / High frequencies of dermatological complications in children using insulin pumps or sensors. In: Pediatric Diabetes. 2018 ; Vol. 19, No. 4. pp. 733-740.

Bibtex

@article{be150bc6f31d4eb19df0472a9e9193bf,
title = "High frequencies of dermatological complications in children using insulin pumps or sensors",
abstract = "BACKGROUND: Dermatological complications in children and adolescents that are related to continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) have not been well-characterized. This study examined the prevalence and characteristics of different types of dermatological complications.METHODS: Online questionnaires regarding dermatological complications related to CSII and/or CGM were returned from a total of 144 children and adolescents, aged 2 to 20 years. Both previous and current skin problems were reported along with their clinical characteristics. Descriptive statistics, χ2 tests, and multivariate analyses were used to evaluate the data.RESULTS: Of 143 patients using CSII, 90% had previous and 63% reported current dermatological complications. Non-specific eczema was most frequently reported and was currently present in 25.7% of the patients. These results were independent of age and current CGM use. Among the 76 patients using CGM, 46% reported current dermatological complications. A history of atopy was associated with dermatological complications in individuals using CSII, but not CGM. The patients rated CGM-related dermal issues as significantly worse than those associated with CSII (P < .05).CONCLUSIONS: Dermatological complications can be a serious problem in treating pediatric and adolescent patients of all ages with CSII and/or CGM. Only a few clinical characteristics associated with these complications were identified in this study, highlighting the need for prospective studies that might lead to improvements in the prevention and treatment of dermatological problems.",
author = "Berg, {Anna Korsgaard} and Olsen, {Birthe Susanne} and Thyssen, {Jacob P} and Claus Zachariae and Simonsen, {Anne Birgitte} and Kasper Pilgaard and Jannet Svensson",
note = "{\textcopyright} 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2018",
doi = "10.1111/pedi.12652",
language = "English",
volume = "19",
pages = "733--740",
journal = "Pediatric Diabetes",
issn = "1399-543X",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - High frequencies of dermatological complications in children using insulin pumps or sensors

AU - Berg, Anna Korsgaard

AU - Olsen, Birthe Susanne

AU - Thyssen, Jacob P

AU - Zachariae, Claus

AU - Simonsen, Anne Birgitte

AU - Pilgaard, Kasper

AU - Svensson, Jannet

N1 - © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PY - 2018

Y1 - 2018

N2 - BACKGROUND: Dermatological complications in children and adolescents that are related to continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) have not been well-characterized. This study examined the prevalence and characteristics of different types of dermatological complications.METHODS: Online questionnaires regarding dermatological complications related to CSII and/or CGM were returned from a total of 144 children and adolescents, aged 2 to 20 years. Both previous and current skin problems were reported along with their clinical characteristics. Descriptive statistics, χ2 tests, and multivariate analyses were used to evaluate the data.RESULTS: Of 143 patients using CSII, 90% had previous and 63% reported current dermatological complications. Non-specific eczema was most frequently reported and was currently present in 25.7% of the patients. These results were independent of age and current CGM use. Among the 76 patients using CGM, 46% reported current dermatological complications. A history of atopy was associated with dermatological complications in individuals using CSII, but not CGM. The patients rated CGM-related dermal issues as significantly worse than those associated with CSII (P < .05).CONCLUSIONS: Dermatological complications can be a serious problem in treating pediatric and adolescent patients of all ages with CSII and/or CGM. Only a few clinical characteristics associated with these complications were identified in this study, highlighting the need for prospective studies that might lead to improvements in the prevention and treatment of dermatological problems.

AB - BACKGROUND: Dermatological complications in children and adolescents that are related to continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) have not been well-characterized. This study examined the prevalence and characteristics of different types of dermatological complications.METHODS: Online questionnaires regarding dermatological complications related to CSII and/or CGM were returned from a total of 144 children and adolescents, aged 2 to 20 years. Both previous and current skin problems were reported along with their clinical characteristics. Descriptive statistics, χ2 tests, and multivariate analyses were used to evaluate the data.RESULTS: Of 143 patients using CSII, 90% had previous and 63% reported current dermatological complications. Non-specific eczema was most frequently reported and was currently present in 25.7% of the patients. These results were independent of age and current CGM use. Among the 76 patients using CGM, 46% reported current dermatological complications. A history of atopy was associated with dermatological complications in individuals using CSII, but not CGM. The patients rated CGM-related dermal issues as significantly worse than those associated with CSII (P < .05).CONCLUSIONS: Dermatological complications can be a serious problem in treating pediatric and adolescent patients of all ages with CSII and/or CGM. Only a few clinical characteristics associated with these complications were identified in this study, highlighting the need for prospective studies that might lead to improvements in the prevention and treatment of dermatological problems.

U2 - 10.1111/pedi.12652

DO - 10.1111/pedi.12652

M3 - Journal article

C2 - 29484783

VL - 19

SP - 733

EP - 740

JO - Pediatric Diabetes

JF - Pediatric Diabetes

SN - 1399-543X

IS - 4

ER -

ID: 213035650